Found: 10

Select item for more details and to access through your institution.

  • Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity.

    Published in:
    Human Genomics, 2024, v. 18, n. 1, p. 1, doi. 10.1186/s40246-024-00579-8
    By:
    • Kiiski, Johanna I.;
    • Neuvonen, Mikko;
    • Kurkela, Mika;
    • Hirvensalo, Päivi;
    • Hämäläinen, Kreetta;
    • Tarkiainen, E. Katriina;
    • Sistonen, Johanna;
    • Korhonen, Mari;
    • Khan, Sofia;
    • Orpana, Arto;
    • Filppula, Anne M.;
    • Lehtonen, Marko;
    • Niemi, Mikko
    Publication type:
    Article

  • The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer.

    Published in:
    NPJ Breast Cancer, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41523-019-0127-5
    By:
    • Figlioli, Gisella;
    • Bogliolo, Massimo;
    • Catucci, Irene;
    • Caleca, Laura;
    • Lasheras, Sandra Viz;
    • Pujol, Roser;
    • Kiiski, Johanna I.;
    • Muranen, Taru A.;
    • Barnes, Daniel R.;
    • Dennis, Joe;
    • Michailidou, Kyriaki;
    • Bolla, Manjeet K.;
    • Leslie, Goska;
    • Aalfs, Cora M.;
    • ABCTB Investigators;
    • Balleine, Rosemary;
    • Baxter, Robert;
    • Braye, Stephen;
    • Carpenter, Jane;
    • Dahlstrom, Jane
    Publication type:
    Article

  • CYP2C19 loss‐of‐function alleles and use of omeprazole or esomeprazole increase the risk of cardiovascular outcomes in patients using clopidogrel.

    Published in:
    CTS: Clinical & Translational Science, 2023, v. 16, n. 10, p. 2010, doi. 10.1111/cts.13608
    By:
    • Ramste, Markus;
    • Ritvos, Markus;
    • Häyrynen, Sergei;
    • Kiiski, Johanna I.;
    • Niemi, Mikko;
    • Sinisalo, Juha
    Publication type:
    Article

  • Posaconazole‐ibrutinib interaction cannot be avoided by staggered dosing: How to optimize ibrutinib dose during posaconazole treatment.

    Published in:
    British Journal of Clinical Pharmacology, 2024, v. 90, n. 2, p. 557, doi. 10.1111/bcp.15932
    By:
    • Olkkola, Aleksi M.;
    • Tapaninen, Tuija;
    • Tornio, Aleksi;
    • Hauta‐aho, Milka;
    • Lapatto‐Reiniluoto, Outi;
    • Neuvonen, Mikko;
    • Kiiski, Johanna I.;
    • Neuvonen, Pertti J.;
    • Niemi, Mikko;
    • Backman, Janne T.
    Publication type:
    Article

  • High miR-30 Expression Associates with Improved Breast Cancer Patient Survival and Treatment Outcome.

    Published in:
    Cancers, 2021, v. 13, n. 12, p. 2907, doi. 10.3390/cancers13122907
    By:
    • Jamshidi, Maral;
    • Fagerholm, Rainer;
    • Muranen, Taru A.;
    • Kaur, Sippy;
    • Potdar, Swapnil;
    • Khan, Sofia;
    • Netti, Eliisa;
    • Mpindi, John-Patrick;
    • Yadav, Bhagwan;
    • Kiiski, Johanna I.;
    • Aittomäki, Kristiina;
    • Heikkilä, Päivi;
    • Saarela, Jani;
    • Bützow, Ralf;
    • Blomqvist, Carl;
    • Nevanlinna, Heli
    Publication type:
    Article

  • Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin.

    Published in:
    Clinical Pharmacology & Therapeutics, 2024, v. 115, n. 1, p. 71, doi. 10.1002/cpt.3067
    By:
    • Lehtisalo, Minna;
    • Tarkiainen, E. Katriina;
    • Neuvonen, Mikko;
    • Holmberg, Mikko;
    • Kiiski, Johanna I.;
    • Lapatto‐Reiniluoto, Outi;
    • Filppula, Anne M.;
    • Kurkela, Mika;
    • Backman, Janne T.;
    • Niemi, Mikko
    Publication type:
    Article

  • NTHL1 is a recessive cancer susceptibility gene.

    Published in:
    Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-47441-w
    By:
    • Nurmi, Anna K.;
    • Pelttari, Liisa M.;
    • Kiiski, Johanna I.;
    • Khan, Sofia;
    • Nurmikolu, Mika;
    • Suvanto, Maija;
    • Aho, Niina;
    • Tasmuth, Tiina;
    • Kalso, Eija;
    • Schleutker, Johanna;
    • Kallioniemi, Anne;
    • Heikkilä, Päivi;
    • FinnGen;
    • Palotie, Aarno;
    • Daly, Mark;
    • Riley-Gillis, Bridget;
    • Jacob, Howard;
    • Paul, Dirk;
    • Petrovski, Slavé;
    • Runz, Heiko
    Publication type:
    Article

  • Recurrent moderate‐risk mutations in Finnish breast and ovarian cancer patients.

    Published in:
    International Journal of Cancer, 2019, v. 145, n. 10, p. 2692, doi. 10.1002/ijc.32309
    By:
    • Nurmi, Anna;
    • Muranen, Taru A.;
    • Pelttari, Liisa M.;
    • Kiiski, Johanna I.;
    • Heikkinen, Tuomas;
    • Lehto, Sini;
    • Kallioniemi, Anne;
    • Schleutker, Johanna;
    • Bützow, Ralf;
    • Blomqvist, Carl;
    • Aittomäki, Kristiina;
    • Nevanlinna, Heli
    Publication type:
    Article

  • FANCM c.5101C>T mutation associates with breast cancer survival and treatment outcome.

    Published in:
    International Journal of Cancer, 2016, v. 139, n. 12, p. 2760, doi. 10.1002/ijc.30394
    By:
    • Kiiski, Johanna I.;
    • Fagerholm, Rainer;
    • Tervasmäki, Anna;
    • Pelttari, Liisa M.;
    • Khan, Sofia;
    • Jamshidi, Maral;
    • Mantere, Tuomo;
    • Pylkäs, Katri;
    • Bartek, Jiri;
    • Bartkova, Jirina;
    • Mannermaa, Arto;
    • Tengström, Maria;
    • Kosma, Veli‐Matti;
    • Winqvist, Robert;
    • Kallioniemi, Anne;
    • Aittomäki, Kristiina;
    • Blomqvist, Carl;
    • Nevanlinna, Heli
    Publication type:
    Article

  • RAD51B in Familial Breast Cancer.

    Published in:
    PLoS ONE, 2016, v. 11, n. 5, p. 1, doi. 10.1371/journal.pone.0153788
    By:
    • Pelttari, Liisa M.;
    • Khan, Sofia;
    • Vuorela, Mikko;
    • Kiiski, Johanna I.;
    • Vilske, Sara;
    • Nevanlinna, Viivi;
    • Ranta, Salla;
    • Schleutker, Johanna;
    • Winqvist, Robert;
    • Kallioniemi, Anne;
    • Dörk, Thilo;
    • Bogdanova, Natalia V.;
    • Figueroa, Jonine;
    • Pharoah, Paul D. P.;
    • Schmidt, Marjanka K.;
    • Dunning, Alison M.;
    • García-Closas, Montserrat;
    • Bolla, Manjeet K.;
    • Dennis, Joe;
    • Michailidou, Kyriaki
    Publication type:
    Article